Featured

Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels

As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for the Factbook described their stores are […]

Read More

Walmart Canada ‘fact-finding’ on potential for CBD product sales

The world’s largest retailer, Walmart, is considering selling CBD products in Canada, a development that comes just days before recreational marijuana markets open in the country. But Walmart says it isn’t ready to start selling cannabidiol just yet. “As we would for any new industry, Walmart Canada has done some preliminary fact-finding on this issue,” […]

Read More

3 business takeaways from the Heineken hemp trademark case

Hemp is a booming new industry, but some of the obstacles facing entrepreneurs are decidedly old. That’s the case for a startup hemp beer seeking trademark protection for its new brand, which is running headfirst into a global alcohol giant: Heineken. The dispute centers on a Pennsylvania company’s plans to release a hemp-infused beer, Tiger […]

Read More

What Farm Bill? Hemp industry shrugs off law’s expiration

The law that ushered in the modern hemp industry in the United States has expired, but hemp growers, processors and retailers are counting on legal assurances that the nation’s experiment in allowing limited hemp production won’t immediately end.

The 2014 Farm Bill, which authorized hemp production under state research programs, expired Sunday – the last day of the federal fiscal year.

Read More

DEA takes some CBD off Schedule 1 – with FDA approval

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

Read More

‘One day you’re legal, the next day you’re not’: Confusion from spotty CBD enforcement

CBD producers and retailers in some of the nation’s largest markets say they’re pressing on despite hostile statements from their state regulators that CBD won’t be allowed. Bans in several markets have largely been met with spotty enforcement, CBD entrepreneurs say, and the impact to business has been mixed. Ohio is one of the latest […]

Read More